Skip to main content

Research Services Division

Deakin Research

Research Output for Dr Guy Krippner

Note: The 2012, 2013, 2014, 2015 publications have not been audited.

Jump to: Publications | Grants and Consultancies | HDR completions

Dr Guy Krippner may be from another institution or only recently joined Deakin University.

Publications

2014 External

Simpson,RW*, Nicholson,GC*, Proietto,J*, Sarah,A*, Sanders,KM*, Phillips,G*, Chambers,J*, MacGinley,R, Orford,N, Walder,K, Krippner,G*, Skoff,K* and Wacher,VJ* (2014) Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study, Diabetes Care, vol. 37, no. 11, pp. 3121-3123, American Diabetes Association, Alexandria VA. [C1]
ERA journal ID: 16018 – Scopus EID: 2-s2.0-84910122260
DRO entry for this publication

2012 External

Konstantopoulos, Nicky, Molero, Juan C., McGee, Sean L., Spolding, Briana, Connor, Tim, de Vries, Melissa, Wanyonyi, Stephen, Fahey, Richard, Morrison, Shona, Swinton, Coutney, Jones, Sharon, Cooper, Adrian, Garcia-Guerra, Lucia, Foletta, Victoria C., Krippner, Guy*, Andrikopoulos, Sofianos* and Walder, Ken R. (2012) Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo, Diabetes, vol. 61, no. 8, pp. 2146-2154, American Diabetes Association, Alexandria, Va. [C1]
ERA journal ID: 16015 – Scopus EID: 2-s2.0-84864378844
Citation counts: Scopus - 1, Thomson - 1
DRO entry for this publication

2011 External

Konstantopoulos, Nicky, Foletta, Victoria C., Segal, David H., Shields, Katherine A.*, Sanigorski, Andrew, Windmill, Kelly, Swinton, Courtney, Connor, Tim, Wanyonyi, Stephen, Dyer, Thomas D.*, Fahey, Richard P., Watt, Rose A., Curran, Joanne E.*, Molero, Juan-Carlos, Krippner, Guy*, Collier, Greg R.*, James, David E.*, Blangero, John*, Jowett, Jeremy B.* and Walder, Ken R. (2011) A gene expression signature for insulin resistance, Physiological genomics, vol. 43, no. 3, pp. 110-120, American Physiological Society, Bethesda, Md. [C1]
ERA journal ID: 14629 – Scopus EID: 2-s2.0-79951870962
Citation counts: Scopus - 3, Thomson - 1
DRO entry for this publication

2008 External

Walder, K. R., Molero, J. C., Konstantopoulos, N., Segal, D., Foletta, V., Windmill, K., Curran, J.*, Dyer, T.*, Shields, K.*, Jowett, J.*, Krippner, G.*, Blangero, J.* and Collier, G.* (2008) Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo, Diabetologia : clinical and experimental diabetes and metabolism, vol. 51, no. Supplement 1, pp. S374-S375, Springer, Berlin, Germany [C2.1]
ERA journal ID: 16025 – Scopus EID: Not tagged
DRO entry for this publication

Walder, K., Molero, J., Konstantopoulos, N., Segal, D. H., Foletta, V., Windmill, K., Curran, J.*, Dyer, T.*, Shields, K.*, Jowett, J.*, Krippner, G.*, Blangero, J.* and Collier, G. R. (2008) Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo, in Unknown (ed.), ADS-ADEA 2008 : Proceedings of the Australian Diabetes Society & Australian Diabetes Educators Association 2008 annual scientific meeting, ADS & ADEA, Melbourne, Vic. [E3.1]
DRO entry for this publication

Grants and Consultancies

All years

Research Income - National Competitive Grants

Walder, K, Pfeffer, F, Konstantopoulos, N and Krippner, G*. Discovery and development of novel insulin sensitising compounds for the treatment of Type 2 diabetes, ARC Collaborative - Linkage - Projects (Round 1) [T]

  • 2012: $139,973
  • 2011: $88,130
  • 2010: $86,764
  • 2012: $127,200
  • 2011: $174,725
  • 2010: $146,043

Higher Degree by Research Completions supervised by Dr Guy Krippner

No completions found or audited.

Legend:
* Not a member of Deakin University at time of output.

DRO to publications collection last synchronised: Thursday 28th May 2015 10:04pm

Deakin University acknowledges the traditional land owners of present campus sites.

4th May 2015